In addition, we explored that expression levels of LAMP-1 in VPA-treated NPC-groups (iNSCs and fibroblasts) were significantly decreased (Figure 5D and Supplementary Figure 5D). This evidence concerns the gene LAMP1 and nasopharyngeal carcinoma.